Companies › LBRX

LB PHARMACEUTICALS INC (LBRX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001691082 · EDGAR filings · Updated 2026-07-22

LB PHARMACEUTICALS INC (LBRX) has reported institutional ownership of 98.4%, with 77 institutional managers holding positions valued at $692.4M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-22 — Prospectus supplement (424B3) filed
• 2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-16 — SCHEDULE 13G filed
• 2026-06-10 — Prospectus supplement (424B3) filed
• 2026-06-10 — Current report (8-K) filed
• 2026-06-09 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LB PHARMACEUTICALS INC has 77 institutional holders and institutional ownership of 98.4%.

Insider activity

Insiders reported 11 transactions (6 buys, 0 sells) across 10 reporting insiders, with a net reported value of $75.0M.

Data flags from SEC filings

Related companies

SOLID BIOSCIENCES INC (SLDB) · VOR BIOPHARMA INC (VOR) · JADE BIOSCIENCES INC (JBIO) · KURA ONCOLOGY INC COM (KURA) · CASTLE BIOSCIENCES INC (CSTL) · BRIGHT MINDS BIOSCIENCES INC (DRUG)